Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis
Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis
Not yet recruiting · NCT06961383 · Registry updated 2025-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Not yet recruiting | Phase 2 | 2025-05-07 | NCT06961383 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NeuroGenesis Ltd. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hadassah University Hospital | Jerusalem | Israel | 3 |
| University of Miami Hospital & Clinics - Sylvester Comprehensive Cancer Center - Neurology | Miami | United States | 1 |